How the Health Management Sector Drives Healthy China Initiative under New Dynamics and Landscape
/
With the rapid development of the social economy and the accelerating pace of life, chronic diseases are becoming a major threat to people both now and in the future. Of the 58 million deaths worldwide in 2009, approximately 36 million were attributed to chronic diseases. As an important strategy and measure for addressing chronic diseases, health management is gaining increasing awareness and attention.
Against the backdrop of the “comprehensive, full-lifecycle health services” mandate outlined in the 14th Five-Year Plan, higher demands and standards have been set for tertiary sector services such as health management. Policy emphasis has shifted upstream in disease management, facilitating a transition from treatment to prevention, including for chronic diseases. The Healthy China 2030 Planning Outline explicitly identifies reducing premature mortality from major chronic diseases as one of its key indicators, calling for the implementation of comprehensive chronic disease prevention and control strategies, with the goal of achieving chronic disease health management for the entire population across the full lifecycle by 2030.
Driven by rising living standards and an aging population, public attention to personal health has intensified, fostering the gradual growth and expansion of the health industry. Since 2016, China has entered a phase of vigorous development in health management. With the release of the Outline of the Healthy China 2030 Plan, the state has explicitly endorsed health management assessment services, marking the formal entry of China’s health management sector into a period of sustained growth.
Downstream participants in China’s health management industry can be categorized into corporate clients and individual clients. Corporate clients account for approximately 70%, primarily comprising multinational corporations and large state-owned enterprises, while individual clients make up the remaining 30%, mostly consisting of high-net-worth individuals. With the development of the internet, private-domain traffic has come into prominence. In contrast to the uncertainty and public nature of public-domain traffic, private-domain traffic typically offers greater privacy, enhanced credibility, and stronger accessibility.
In recent years, with the updates and advancements in artificial intelligence, big data, and internet technologies, “digital” reforms have broken down the previous “information silos” within hospitals, making data more transparent and accessible. This has also enhanced customer proximity. By fully leveraging private-domain traffic and capturing downstream customers, the health management industry can achieve better development. As health awareness becomes increasingly ingrained in public consciousness, individual demand for health management services is growing stronger. Future demand urgently needs to be further unleashed, serving as a key driving force for the expansion of the health management market.
The “Internet + Healthcare” policy has begun to permeate the upstream sectors of the health management industry in recent years, not only driving medical device companies to establish e-commerce platforms but also more precisely and comprehensively meeting consumer demands. The emergence of emerging technologies, such as artificial intelligence, 5G, and big data, is propelling “AI+” to become the mainstream direction for the future development of the health management industry.
“AI+” Facilitates Remote Diagnosis and Treatment: By leveraging artificial intelligence algorithms to empower medical devices and equipment, a remote healthcare service platform is established. This approach enhances accuracy and convenience. As AI algorithms possess deep learning capabilities, their precision continuously improves with the accumulation of patient sample data. Consequently, AI-assisted medical devices make precise judgments purely from a data-driven perspective and are available on demand, unaffected by spatial constraints or human factors, thereby offering significant convenience to home users. Artificial intelligence empowers the health management industry, driving its development.
According to publicly available data, 48% of employees in Chinese enterprises are in a state of “sub-health.” Sub-health is no longer a novel term. A survey conducted by China’s Ministry of Health among office workers in ten cities revealed that the prevalence of sub-health had reached 60%, particularly in economically developed regions. The direct consequences of sub-health include reduced work efficiency and diminished labor value creation. Prolonged sub-health status poses significant harm to both the physical and mental well-being of employees. Therefore, effective health management for corporate employees is of critical importance.
By fully leveraging big data platforms and analytics, and by establishing an enterprise health management platform, organizations can rapidly connect to various high-quality healthcare resources through the platform’s capabilities. Through digital technology analysis, comprehensive lifelong digital health records for employees can be swiftly developed. Furthermore, algorithms can predict the likelihood of employees developing specific diseases or dying from such conditions within a given timeframe. Based on individual employee needs, targeted control measures, interventions, and personalized health management plans can be provided. The enterprise health management platform also delivers timely, convenient, and efficient online diagnosis and treatment services to employees.
Modern health management models shift the focus upstream by implementing preventive interventions to address and control risk factors before disease onset. By modifying individual lifestyles and behavioral habits, these models aim to slow or reverse disease progression and improve overall health status.
As the “Internet + Healthcare” policy continues to advance, it has become an inevitable trend that health management innovation in the post-pandemic era empowers individual health. Digital therapeutics, as well as oncology and chronic disease management, have become the focal points of the industry. This development is driven by the goals of facilitating economic growth and industrial structural transformation, and contributing to the construction of a Healthy China.June 15, 2022, Future Healthcare Top 100 Conference — Health Management Innovation Forum will explore industry trends from the perspectives of national policies and industrial transformation and upgrading, address multidisciplinary issues spanning academia, R&D, manufacturing, application, and investment, and build a platform for industrial exchange, cooperation, and integration.
Editor:Wang Meilin
Forum Date: June 15, 2022 Day 2
Venue: Shishan International Conference Center, Suzhou, Jiangsu
Forum Organizers: VB100, VCBeat, Arterial Orange, VCBeat Research Institute
● 09:00-09:20
Amid the Rapid Penetration of Digital Technologies, Significant Breakthroughs in the “Quality” and “Efficiency” of Health Management(Draft)
Innovative Enterprises in Related Fields in China
● 09:20-09:40
How AI and Big Data Can Provide Systematic Health Management for Enterprise Employees (Proposed)
Lejian Health Technology Group
● 09:40-10:00
Commercial Insurance-Driven Cost-Control Solutions Under the Public-Private Partnership Model
Li Ruining | Founder and CEO of Huiyi Health
● 10:00-10:20
The Leap from Private Domain Traffic to the Medical Services Sector (Draft)
Lai Gangbin | CEO of Jingli Technology
● 10:20-10:40
How Digital Therapeutics Empower Pain Management in the Niche Field of Chronic Pain (Proposed)
Luo Min | Co-founder and CEO of Tengai Health
● 10:40-11:00
Tech Innovation Services: Building a “Body-Mind Unity” Full-Lifecycle Digital Health Platform (Proposed)
Quege Digital Health Group
● 11:00-11:20
Applications (Proposed) in New Scenarios of Health Management
Ning You | Founder and CEO of Jingyiwei
● 11:20-12:00
Roundtable with Industry Leaders: Technology or Business Model—Which Is the Future Direction of China’s Health Management Industry? (Proposed)
Top Investment Institutions in China/Related FieldsInnovative Enterprises
● Mapping the Industry Landscape, Telling China’s Story: The 2022 Top 100 Future Healthcare Conference Held with Strong Momentum
From “Eye of the Storm,” “Species Big Bang,” “Tide Direction ING,” and “New Growth of Life” to “The Calculation of Life”; from 20 speakers, 150 companies, and 400 attendees at the inaugural event to a cumulative total of over 1,000 domestic and international speakers, more than 5,000 participating companies, over 20,000 attendees, and 5 million+ impressions… The Top 100 Future Healthcare Conference has grown alongside China’s medical and health industry, continuously expanding to become the largest-scale and most information-rich summit integrating industry and capital within China’s healthcare innovation sector.
The 6th Future Healthcare Top 100 Conference will be held at the Shishan International Convention Center in Suzhou, Jiangsu Province. This year, we will collaborate with embassies from various countries to jointly host a global roadshow for innovative healthcare projects. Embarking with a renewed vision, we will focus on “China’s Story,” ground ourselves in innovation, and faithfully document the evolution of the global healthcare industry. We will identify leading innovative enterprises in the sector and analyze industry hotspots from five dimensions: policy orientation, technological frontiers, capital perspectives, industrial innovation, and market demand. By interpreting development trends in the future healthcare industry, we aim to drive transformative change in the innovative healthcare sector. Our goal is to gather core industry forces, promote transformation in the innovative healthcare industry, and build a comprehensive exchange and matchmaking platform for the entire medical and health industrial chain.
● A Convergence of Multiple Highlights: Creating the Premier 2022 Domestic Healthcare Industry Event
Top-Tier Guest Lineup—Led by Academician Scientists300+ Distinguished GuestsBringing three days of cutting-edge medical technology, industry trends, and business innovation
Business Wisdom of Industry Leaders——In ChinaStrategic Launch by Benchmark Listed Companies, Insights into the Future of the Industry and the Innovation Landscape
Global Perspective and Overseas Resources—— FromUnited Kingdom, Canada, Belgium...industrial development trends and capital markets in multiple countries, linking high-quality overseas technological innovation projects
In-Depth Insights into Niche Sectors——Major Announcement6 Industry Research Series Reports, Exploring Development Opportunities and Innovative Cases in Niche Fields
Converging the Core Forces of Future Healthcare—— Release5 Top 100 Lists and 2 Awards, bringing together 1,000+ unicorns and high-potential innovative enterprises to jointly explore pathways for innovative development
Forward-Looking Capital Perspective——100+ including GPs, LPs, CVCs, VCs, PEs, FAs, etc.Financial Institutions as Forward-Looking Investors: Sensing the Direction of Capital Heat in the Industry
/
Conference Dates: June 14–16, 2022
Venue: Shishan International Conference Center, Suzhou, China
Limited-Time Offer: Conference All-Access Pass
Purchase Channels:Search for the “VB100” mini-program on WeChat to make a purchase.
Two types of general admission passes are available for public sale at this conference:
RMB 899 [VB100 All-Access Pass, Meals Not Included]¥1,299 [VB100 All-Access Pass with Meals]Limited-Time Offer · Conference All-Access PassSave ¥630 off the original price, now as low as ¥269Onset:
Your trust will entitle you to the following benefits:
1. All-Access Pass for Forum, Exhibition, and Interactive Events (Separate registration required for certain segments such as LPGP)
2. On-Site Resource Coordination and Communication Group
3. Guest-authorized limited materials, including PPTs, conference proceedings, and public reports
4. Lunch vouchers during the conference (only for those with meal tickets)
Special Note:
1. Duration of This Limited-Time OfferUpdates on Key Milestones from Today Until the Next Meeting;
2. Ticket prices will be adjusted as information regarding the conference theme, speakers, topics, and exhibitors is revealed,Increase by 100 yuan each time until the original price is restored;
3、After this limited-time offer ends,Ticket prices will rise to 369 yuan.Qi
Scan the QR code to register for the 2022 · 6th Future Healthcare Top 100 Conference
Inquiry for the 2022 Future Healthcare Top 100 Conference
